SCYNEXIS, Inc. Earnings Per Share, Basic and Diluted
SCYNEXIS, Inc. (SCYX) reported Earnings Per Share, Basic and Diluted of -$0.02 per share for the 3-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2017-03-13
- SCYNEXIS, Inc. earnings per share, basic and diluted for the quarter ending 2016-12-31 was -$0.02.
- SCYNEXIS, Inc. earnings per share, basic and diluted for the quarter ending 2016-09-30 was -$0.48.
- SCYNEXIS, Inc. earnings per share, basic and diluted for the quarter ending 2016-06-30 was -$0.56.
- SCYNEXIS, Inc. earnings per share, basic and diluted for the quarter ending 2016-03-31 was -$0.52.
- SCYNEXIS, Inc. earnings per share, basic and diluted for fiscal 2016 was -$1.58.
- SCYNEXIS, Inc. earnings per share, basic and diluted for fiscal 2015 was -$2.68.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$0.02 10-K · filed 2017-03-13 | -$1.58 10-K · filed 2017-03-13 | ||
| 2016-09-30 | -$0.48 10-K · filed 2017-03-13 | -$1.53 10-Q · filed 2016-11-07 | ||
| 2016-06-30 | -$0.56 10-K · filed 2017-03-13 | |||
| 2016-03-31 | -$0.52 10-K · filed 2017-03-13 | |||
| 2015-12-31 | -$0.55 10-K · filed 2017-03-13 | -$2.68 10-K · filed 2017-03-13 | ||
| 2015-09-30 | -$0.60 10-K · filed 2017-03-13 | -$1.37 derived: net income ÷ weighted average shares · filed 2016-11-07 | -$2.09 10-Q · filed 2016-11-07 | |
| 2015-06-30 | -$0.78 10-K · filed 2017-03-13 | -$1.53 derived: net income ÷ weighted average shares · filed 2016-08-08 | ||
| 2015-03-31 | -$0.75 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |